Cereno Scientific solidifies CS1’s patent protection with new European patent
Cereno Scientific (XSAT: CRNO B) today announced that the European Patent Office (EPO) has granted a patent for CS1’s second patent family. The new patent adds to the existing intellectual property rights (IPR) for this strategically important market which now covers two of Cereno’s three patent families.“I am pleased to see a further strengthening of our patent protection for CS1 in Europe, one of the largest markets for pharmaceutical products globally. Adding to our patent protection in Australia, Canada, Japan, Russia and the US, I believe we are building a strong IPR position for CS1,”